VERU INC.
VERU$64M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaMIAMI
Drugs in Pipeline
4
Phase 3 Programs
1
Upcoming Catalysts
1
Next Catalyst
Aug 11, 2026
7wMarket Overview
Stock performance and key metrics
VERU News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
Veru-111
Respiratory Distress Syndrome, Adult
Veru-944
Prostate Cancer Metastatic
Enobosarm
Muscle Loss
Semaglutide (Wegovy) weekly injection
Obesity & Overweight
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Veru-111 | Phase 3 | Respiratory Distress Syndrome, Adult | - | - |
Veru-944 | Phase 2 | Prostate Cancer Metastatic | - | - |
Enobosarm | Phase 2 | Muscle Loss | - | - |
Semaglutide (Wegovy) weekly injection | Phase 2 | Obesity & Overweight | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply